Murae Organisor (BOM:542724) Debt-to-EBITDA : 0.00 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Murae Organisor Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Murae Organisor's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.00 Mil. Murae Organisor's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.00 Mil. Murae Organisor's annualized EBITDA for the quarter that ended in Dec. 2023 was ₹2.24 Mil. Murae Organisor's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Murae Organisor's Debt-to-EBITDA or its related term are showing as below:

BOM:542724' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.7 Med: 3.01 Max: 9.73
Current: 8.17

During the past 8 years, the highest Debt-to-EBITDA Ratio of Murae Organisor was 9.73. The lowest was 2.70. And the median was 3.01.

BOM:542724's Debt-to-EBITDA is ranked worse than
89.8% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs BOM:542724: 8.17

Murae Organisor Debt-to-EBITDA Historical Data

The historical data trend for Murae Organisor's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Murae Organisor Debt-to-EBITDA Chart

Murae Organisor Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-EBITDA

Get a 7-Day Free Trial

2.95

2.70

9.73

2.97

2.74

Murae Organisor Quarterly Data
	Mar18	Sep18	Dec18	Mar19	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial															-	1.81	-	-0.66	-

Competitive Comparison of Murae Organisor's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Murae Organisor's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Murae Organisor's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Murae Organisor's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Murae Organisor's Debt-to-EBITDA falls into.

Murae Organisor Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Murae Organisor's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(87.399	+	0)	/	31.894
	=	2.74

Murae Organisor's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0	+	0)	/	2.244
	=	0.00

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

Murae Organisor (BOM:542724) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Murae Organisor Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Murae Organisor's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Murae Organisor (BOM:542724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Murae Organisor Ltd (BOM:542724) » Definitions » Debt-to-EBITDA

Traded in Other Exchanges

N/A

Address

Science City Road, A-1106, Empire Business Hub, Near Auda Water Tank, Sola, Ahmedabad, GJ, IND, 380060

Website

http://www.earumpharma.com

Murae Organisor Ltd Formerly Earum Pharmaceuticals Ltd is engaged in the pharmaceutical business. It is involved in the marketing, trading, and distribution of a wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, dermatology products, cerebral activator drugs, neurological drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. It offers a wide range of pharmaceutical formulation products that are marketed under its brand name. Apart from pharmaceutical formulation products, the company also deals in the trading of active pharmaceutical ingredients.

Murae Organisor (BOM:542724) Headlines

No Headlines